开发和验证用于预测中枢神经系统初级生殖细胞瘤患者的整体存活率
Dunchen Yao1, Baokui Ye2, Hongli Zhang3
1Department of Oncology, The Second People's Hospital of Guiyang, Guiyang, China.
Frontiers in immunology
|September 5, 2025
概括
这项研究使用了七个因子开发了中枢神经系统 (CNS) 胚胎细胞瘤的预后表. 该工具可以准确预测儿童和青少年的整体存活率.
科学领域:
- 神经瘤学
- 儿童瘤学
- 癌症流行病学
背景情况:
- 主要的中枢神经系统 (CNS) 生殖细胞瘤 (GCTs) 在儿童和青少年群体中普遍存在.
- 鉴定预后因素对于有效管理中枢神经系统GCT至关重要.
- 准确预测整体存活率对于治疗计划至关重要.
研究的目的:
- 确定中枢神经系统GCT的独立预后因素.
- 开发和验证用于预测中枢神经系统GCT患者的OS.
- 为中枢神经系统的GCT建立一个风险分层系统.
主要方法:
- 使用来自SEER计划的大型开发队列 (1166名患者) 和来自SYSUCC的验证队列 (165名患者).
- 应用多变量考克斯回归分析以确定显著的预后变量.
- 使用C指数,校准曲线,时间依赖的AUC和DCA验证了名图的性能.
主要成果:
- 开发了一种包含年龄,性别,组织病理学,扩散,瘤大小,放射治疗和化疗的诺姆图.
- 诺米图表显示出良好的分辨能力,C指数为0.773 (发育) 和0.712 (验证).
- 通过有效的风险分组,诺莫图显示出对预后估计和治疗决策的临床实用性.
结论:
- 对中枢神经系统GCTs成功开发了一种精确和临床有用的预后表.
- 诺米图帮助临床医生准确估计预后并指导治疗策略.
- 这种工具支持中枢神经系统GCT患者的个性化长期治疗.
更多相关视频
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
372
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
193
相关概念视频
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Dosage Regimen Designs: Nomograms and Tabulations
360
Nomograms and tabulations are vital tools used by clinicians to design accurate and individualized dosage regimens. These instruments provide a straightforward method for adjusting dosages based on individual patient characteristics, including age, weight, and physiological condition. The foundation of a drug's nomogram is population pharmacokinetic data collected and analyzed using specific models. This data simplifies complex equations, presenting them diagrammatically or tabularly for easy...
360
Cancer Survival Analysis
870
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
870
